pH and other effects on the antifungal activity of cilofungin (LY121019)
- 1 May 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (5), 731-735
- https://doi.org/10.1128/aac.33.5.731
Abstract
We investigated the effects of various test conditions on broth macro- and microdilution susceptibility test results for several species of yeasts with a new antifungal agent, cilofungin. As the pH decreased from 7.4 to 3.0, 50% inhibitory concentrations (IC1/2) increased up to 64-fold. This effect was unrelated to yeast growth rate, solvent concentration, or choice of buffer. Broth microdilution results for 42 Candida albicans isolates at pH 7.4 in synthetic amino acid medium, fungal (SAAMF), showed IC1/2 results from 0.08 to 2.5 micrograms/ml, whereas at pH 3.0 the results were 5.0 or 10.0 micrograms/ml. Fungicidal concentrations were closer to MIC results at the lower pH, i.e., an average of 16-fold above the MIC at pH 3.0, compared with an average 256-fold difference at pH 7.4. Two strains that had very different IC1/2 results at pH 7.4 and identical IC1/2 results at pH 3.0 were found to be equally susceptible to cilofungin therapy in rats. In additional studies, other medium effects were demonstrable, with yeast nitrogen broth and minimal essential medium generally yielding higher results than two other synthetic media (SAAMF and RPMI 1640 medium). However, susceptibility results did not change with inoculum between 10(2) and 10(5) yeast cells per ml or temperature between 30 and 37 degrees C. These studies indicate that pH is an important influence on in vitro rank order susceptibility of pathogenic yeasts to cilofungin.This publication has 23 references indexed in Scilit:
- Anti-Candida Activity and Toxicology of LY121019, a Novel Semisynthetic Polypeptide Antifungal AntibioticAnnals of the New York Academy of Sciences, 1988
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Echinocandin inhibition of 1,3‐β‐D‐glucan synthase from Candida albicansFEBS Letters, 1984
- Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis ModelThe Journal of Infectious Diseases, 1983
- Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factorsAntimicrobial Agents and Chemotherapy, 1983
- Effects of pH on the Activity of Ketoconazole Against Candida albicansAntimicrobial Agents and Chemotherapy, 1983
- Increased Arabinitol Levels in Experimental Candidiasis in Rats: Arabinitol Appearance Rates, Arabinitol/Creatinine Ratios, and Severity of InfectionThe Journal of Infectious Diseases, 1982
- Factors Influencing the Susceptibility of Candida albicans to the Polyenoic Antibiotics Nystatin and Amphotericin BJournal of General Microbiology, 1978
- Turbidimetric Studies of Growth Inhibition of Yeasts with Three Drugs: Inquiry into Inoculum-Dependent Susceptibility Testing, Time of Onset of Drug Effect, and Implications for Current and Newer MethodsAntimicrobial Agents and Chemotherapy, 1978
- Obfuscation of the Activity of Antifungal Antimicrobics by Culture MediaThe Journal of Infectious Diseases, 1972